Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight increase, with a closing price of 132.44 yuan on January 21, 2026, reflecting a 0.39% rise, while the overall market activity indicates mixed capital flows among different investor categories [1][2]. Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main revenue of 8.859 billion yuan, representing a year-on-year increase of 27.39% - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year - The non-recurring net profit was 1.053 billion yuan, showing a significant increase of 126.94% - In Q3 2025 alone, the company achieved a main revenue of 2.843 billion yuan, a 75.41% increase year-on-year, and a net profit of 122 million yuan, up 143.8% year-on-year [3]. Market Position and Valuation - United Imaging Healthcare's total market capitalization stands at 109.151 billion yuan, ranking second in the medical device industry - The company has a net asset value of 20.805 billion yuan, ranking third, and a net profit of 1.12 billion yuan, ranking fifth in the industry - The price-to-earnings ratio (P/E) is 73.08, which is lower than the industry average of 99.95, ranking 65th, while the price-to-book ratio (P/B) is 5.25, ranking 103rd [3]. Institutional Ratings - Over the past 90 days, 25 institutions have provided ratings for the stock, with 18 recommending a buy and 7 recommending an increase in holdings - The average target price set by institutions in the last 90 days is 176.35 yuan [4].
股票行情快报:联影医疗(688271)1月21日主力资金净买入1217.27万元